APPENDIX I

ACCOUNTANTS’ REPORT

Issues and fully paid
At 1 January 2016
Issuance of restricted shares (note d)
Issuance of ordinary shares (note e)
Exercise of share options (note f)

At 31 December 2016
Issuance of restricted shares (note g)

At 31 December 2017
Exercise of share options (note h)
Issuance of ordinary shares (note i)
Share subdivision (note c)

At 30 June 2018

Number of
shares

7,670,454
950,000
1,674
346,667

8,968,795
3,020,697

11,989,492
9,010,004
2,235
189,015,579

210,017,310

Equivalent
amount of
ordinary shares
RMB’000

Amount
USD’000

1
–
–
–

1
–

1
1
–
–

2

4
1
–
1

6
2

8
6
–
–

14

Notes:

(a)

(b)

On 23 December 2016, the Company redesignated and reclassified 21,475,179 shares into Series D Preferred
Shares with details set out in note 28.

On 31 January 2018, the Company redesignated and reclassified 11,177,348 shares into Series E Preferred
Shares with details set out in note 28.

(c) With effect from 12 June 2018, each of the Company’s authorised and issued 500,000,000 shares of a par value
of US$0.0001 have be subdivided into ten shares of US$0.00001 par value each so that the authorised share
capital of the Company shall be US$50,000 divided into (i) 4,328,216,600 authorised ordinary shares of a par
value of US$0.00001, (ii) 50,000,000 Series A Preferred Shares of a par value of US$0.00001 each, (iii)
136,363,660 Series B Preferred Shares of a par value of US$0.00001 each, (iv) 158,894,480 Series C Preferred
Shares of a par value of US$0.00001 each, (v) 214,751,780 Series D Preferred Shares of a par value of
US$0.00001 each, (vi) 111,773,480 Series E Preferred Shares of a par value of US$0.00001 each.

(d)

(e)

(f)

(g)

(h)

(i)

During the year ended 31 December 2016, 950,000 restricted shares with subscription price of US$1.10 per
share was issued with details set out in note 30(a).

During the year ended 31 December 2016, the Company issued 1,674 ordinary shares to one of the independent
directors of the Company to settle part of its remuneration payable to him of approximately USD15,000
(equivalent to approximately RMB100,000).

During the year ended 31 December 2016, share option holders exercised their rights to subscribe for 346,667
ordinary shares in the Company at US$0.17 per share.

During the year ended 31 December 2017, 3,020,697 restricted shares with subscription price of US$1.1 per
share issued and vested with details set out in note 30(a).

On 1 May 2018, the Company issued 9,010,004 ordinary shares to Great Biono Fortune LP pursuit to an
acceleration of options granted under the pre-IPO share incentive plan, with a total exercise price of
US$10,076,000 (equivalent to RMB63,874,000). The exercise price of the share options were settled through
current accounts with directors of the Company and other loans to employees of the Group.

During the six months ended 30 June 2018,
the Company issued 2,235 ordinary shares to one of the
independent directors of the Company to settle parts of its remuneration payable to him of approximately
USD30,000 (equivalent to approximately RMB190,000).

– I-53 –

